Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

被引：0
作者：
Masato Yoneda
Takuma Yamamoto
Yasushi Honda
Kento Imajo
Yuji Ogawa
Takaomi Kessoku
Takashi Kobayashi
Asako Nogami
Takuma Higurashi
Shingo Kato
Kunihiro Hosono
Satoru Saito
Atsushi Nakajima
机构：
[1] Yokohama City University Hospital,Department of Gastroenterology and Hepatology
[2] Kowa Company,Cardiovascular and Diabetes, Product Marketing Department
[3] Ltd.,Department of Gastroenterology
[4] Shin-Yurigaoka General Hospital,Department of Gastroenterology
[5] National Hospital Organization Yokohama Medical Center,undefined
来源：
Journal of Gastroenterology | 2021年 / 56卷
关键词：
Cardiovascular disease; Diabetes mellitus; Hypertriglyceridemia; Non-alcoholic fatty liver disease; Metabolic dysfunction associated fatty liver disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1022 / 1032
页数：10
相关论文
共 110 条
[1]  
Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
[2]  
Koenig AB(2019)Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis Lancet Gastroenterol Hepatol 4 389-398
[3]  
Abdelatif D(2014)Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Lancet Diabetes Endocrinol 2 901-910
[4]  
Li J(2020)A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement J Hepatol 73 202-209
[5]  
Zou B(2015)Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 149 389-97.e10
[6]  
Yeo YH(2017)Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD J Hepatol 67 1265-1273
[7]  
Yki-Järvinen H(2019)Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter J Gastroenterol 54 271-280
[8]  
Eslam M(2018)Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients J Hepatol 68 764-772
[9]  
Newsome PN(2010)Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 1341-1350
[10]  
Sarin SK(2012)Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 33 1190-1200
12345678910